Wnt mediates hSVF vascular self-assembly. by Venkat M. Ramakrishnan (2559520)

“…<p><b>(A)</b> The CCK-8 cell cytotoxicity assay demonstrated that IWP2 concentrations ≤ 25μM were not cytotoxic, whereas 50μM was cytotoxic (***<i>p</i> ≤ 0.001). …”

3D spheroids enhance NFAT3 and CXCR4 expression. by Keven Huang (675616)

“…(<b>B</b>) NFAT3 mRNA showed an average of ∼ 20 fold increase in the 3D spheroid. (*, P <0.05 vs Adh, 1-way ANOVA). (<b>C</b>) Corresponding to the increase in NFAT3 in 3D spheroids, real-time PCR showed a 30-50-fold increase in CXCR4 mRNA in 3D spheroids when compared to adherent HeyA8 cells. (*, P <0.05 vs Adh, 1-way ANOVA). …”

Pre-treatment of IOZCAS-Spex-II cells with CPT and HCPT decreased Topo1 specific activity in a dose-dependent manner. by Lan Zhang (90951)

Decreasing ratio (d) and cross sectional radius of gyration (Rc) of CRP2 bound F-actin. by Takanori Kihara (174377)

Mean value of ENSS and subscales. by Phu Dinh Vu (19429477)

“…Overall, participants reported a medium stress level with an Extended Nursing Stress Scale (ENSS) mean score of 1.79 points, and 32.1% had occupational stress. …”

Synthesis and Antiproliferative Activity of a New Series of Mono- and Bis(dimethylpyrazolyl)‑<i>s</i>‑triazine Derivatives Targeting EGFR/PI3K/AKT/mTOR Signaling Cascades by Ihab Shawish (13015516)

“…Compound <b>4f</b> exhibited potent EGFR inhibitory activity with an IC₅₀ value of 61 nM compared to that of Tamoxifen (IC₅₀ value of 69 nM), with EGFR inhibition of 83 and 84%, respectively, at a concentration of 10 μM. …”

Synthesis and Antiproliferative Activity of a New Series of Mono- and Bis(dimethylpyrazolyl)‑<i>s</i>‑triazine Derivatives Targeting EGFR/PI3K/AKT/mTOR Signaling Cascades by Ihab Shawish (13015516)

“…Compound <b>4f</b> exhibited potent EGFR inhibitory activity with an IC₅₀ value of 61 nM compared to that of Tamoxifen (IC₅₀ value of 69 nM), with EGFR inhibition of 83 and 84%, respectively, at a concentration of 10 μM. …”

Decreasing NR1 and NR2A gene expression in 5-, 14- and 21-day groups. by Chenxia Han (4020017)

Inhibition of SKI-1/S1P enzymatic activity using PF-429242 impairs activation of the SREBP pathway and correlates with a dramatic decrease in lipid droplet number and area. by Anastasia Hyrina (3860455)

miR-124 decreases cell proliferation in 2D and 3D cultures. by Alexa Tenga (2161780)

“…As a result, Nur77 mRNA levels were significantly decreased (<i>p</i> < 0.0001). …”

Fourteen days after tMCAo surgery mice with RNS60 treatment show a decrease in microglial activation Iba1 (+) in the CA3 region of the ipsilateral hippocampus. by Gloria Patricia Baena-Caldas (17721328)

Riccardin D decreased expression of β-catenin and cyclin D1 in intestinal polyps. by Hui-Ping Liu (290636)

Likelihood of a decrease in runoff (a), an increase in runoff (b) and a severe change in ecosystems (c) for selected Δ<em>T</em>_g levels by Dieter Gerten (557088)

“…</strong> Likelihood of a decrease in runoff (a), an increase in runoff (b) and a severe change in ecosystems (c) for selected Δ<em>T</em>_g levels. …”

NB polarity and number are unaffected by knockdown of mitochondrial morphology proteins. by Dnyanesh Dubal (12085942)

Linear regression analysis between ω3-/ω6-PUFA ratio, Body Mass Index (BMI) and pSTAT3 decrease. by Massimo D’Archivio (467635)

“…<p>Correlation between the ω3-/ω6-PUFA ratio and the percentage of pSTAT3 decrease after DHA treatment in control subjects (n=10) (<b>A</b>) and cancer subjects (n=14) (<b>B</b>). …”

The global transcription is decreased in VBNC but remains specific. by Benjamin Hommel (523072)

“…<i>cerevisiae</i> spiked in each sample showed a significant decrease in VBNC compared to other conditions <b>B</b>. …”

Analysis of change in mature INPs, GMCs and neurons in the type II NB lineage on depletion of mitochondrial morphology proteins. by Dnyanesh Dubal (12085942)

Resveratrol induces senescence through activation of p53, p21^CIP1 and p16^INK4A. by Mehtap Kilic Eren (591048)

TMEM182 decreases OSCC cell motility. by En-Wei Hsing (154990)

Summary of pharmacological data for GluN2A(D731N). by Kai Gao (120150)

Subjects: